Skip to Content

GSI 250 (Viread 250 mg)

Generic Name: tenofovir

Pill with imprint GSI 250 is White, Capsule-shape and has been identified as Viread 250 mg. It is supplied by Gilead Sciences, Inc..

Viread is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 250

Viread 250 mg GSI 250

Viread

Generic Name
tenofovir
Imprint
GSI 250
Strength
250 mg
Color
White
Size
15.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
National Drug Code (NDC)
61958-0406
Inactive Ingredients
corn starch, croscarmellose sodium, lactose monohydrate, microcrystalline cellulose, magnesium stearate, titanium dioxide, triacetin, hypromellose 2910 (15000 mPa.s)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.